The ROE (Return on Equity) of Halozyme Therapeutics Inc (HALO) is 122.06%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | 122.06% |
| 2023-12-31 | 336.00% |
| 2022-12-31 | 119.02% |
| 2021-12-31 | 204.42% |
| 2020-12-31 | 85.50% |
| 2019-12-31 | -78.65% |
| 2018-12-31 | -32.26% |
| 2017-12-31 | 30.23% |
| 2016-12-31 | 316.92% |
| 2015-12-31 | -74.88% |